Status:
COMPLETED
Assessment Of Sildenafil On Erectile Function And Intercourse Satisfaction And To Validate A New Subject Questionnaire
Lead Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Conditions:
Impotence
Eligibility:
MALE
18+ years
Phase:
PHASE4
Brief Summary
To evaluate the effectiveness of sildenafil on erectile function and intercourse satisfaction in men with ED as well as to validate the new Sexual Experience Questionnaire which incorporates functiona...
Eligibility Criteria
Inclusion
- Documented clinical diagnosis of erectile dysfunction, defined by a score of less than or equal to 25 on the Erectile Dysfunction domain of the International Index of Erectile Function
Exclusion
- Subjects who have been treated with more than 6 doses of sildenafil or any other phosphodiesterase type 5 inhibitor
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2006
Estimated Enrollment :
209 Patients enrolled
Trial Details
Trial ID
NCT00147628
Start Date
November 1 2005
End Date
September 1 2006
Last Update
February 1 2021
Active Locations (20)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Huntsville, Alabama, United States
2
Pfizer Investigational Site
San Diego, California, United States
3
Pfizer Investigational Site
Aurora, Colorado, United States
4
Pfizer Investigational Site
Miami, Florida, United States